Kynam Capital Management, LP Q3 2022 Filing

Filed November 14, 2022

Portfolio Value

$474.6B

Holdings

35

Report Date

Q3 2022

Filing Type

13F-HR

All Holdings (35 positions)

#StockSharesValue% PortfolioType
1
NTRANATERA INC
2,018,360$88.4B18.64%
2
SNDXSYNDAX PHARMACEUTICALS INC
2,272,915$54.6B11.51%
3
TCE2CELLDEX THERAPEUTICS INC NEW
1,600,127$45.0B9.48%
4
VERAVERA THERAPEUTICS INC
1,536,181$32.7B6.90%
5
UTHUNITED THERAPEUTICS CORP DEL
151,009$31.6B6.66%
6
SNYSANOFI
600,000$22.8B4.81%
7
VRDNVIRIDIAN THERAPEUTICS INC
1,000,000$20.5B4.32%
8
BIIBBIOGEN INC
75,000$20.0B4.22%
9
PCVXVAXCYTE INC
698,638$16.8B3.53%
10
BNRBURNING ROCK BIOTECH LTD
6,703,863$16.0B3.38%
11
GSKGSK PLC
500,000$14.7B3.10%
12
COGTCOGENT BIOSCIENCES INC
985,155$14.7B3.10%
13
CNCEEURCONCERT PHARMACEUTICALS INC
1,673,041$11.2B2.36%
14
TVTXTRAVERE THERAPEUTICS INC
416,729$10.3B2.16%
15
LQDALIQUIDIA CORPORATION
2,200,102$9.2B1.94%Call
16
GBTUSDGLOBAL BLOOD THERAPEUTICS IN
131,220$8.9B1.88%
17
AMRNAMARIN CORP PLC
6,720,148$7.3B1.54%
18
AM6AMICUS THERAPEUTICS INC
676,849$7.1B1.49%
19
BCRXBIOCRYST PHARMACEUTICALS INC
435,117$5.5B1.16%
20
WVEWAVE LIFE SCIENCES LTD
1,397,479$5.0B1.06%
21
MCRB1EURSERES THERAPEUTICS INC
772,820$5.0B1.05%
22
AKOUOS INC
718,394$4.9B1.02%
23
GOSSGOSSAMER BIO INC
386,349$4.6B0.98%
24
PTGXPROTAGONIST THERAPEUTICS INC
519,212$4.4B0.92%
25
OLMAOLEMA PHARMACEUTICALS INC
1,399,633$3.9B0.81%
26
CNTACENTESSA PHARMACEUTICALS PLC
731,521$2.9B0.62%
27
AFFIMED N V
676,675$1.4B0.29%
28
PBYIPUMA BIOTECHNOLOGY INC
559,769$1.3B0.28%
29
XENEXENON PHARMACEUTICALS INC
28,792$1.0B0.22%
30
CNTBCONNECT BIOPHARMA HLDGS LTD
739,649$954.0M0.20%
31
RLMDRELMADA THERAPEUTICS INC
300,000$803.0M0.17%Put
32
1T7TRICIDA INC
357,600$460.0M0.10%Put
33
CABACABALETTA BIO INC
527,805$343.0M0.07%
34
NEOLEUKIN THERAPEUTICS INC
120,368$77.0M0.02%
35
GYRECATALYST BIOSCIENCES INC
90,188$45.0M0.01%